Over 40 years, Berlow has treated more than 1,000 children with cancer

"Today it is possible to cure a child with cancer," said Marco Rabusin, director of pediatric oncohematology in Burlo, on the occasion of the World Congress against childhood cancer."The result is the result of significant advances in the technological field, ass

In 40 years, Burlo has treated more than a thousand children suffering from cancer

Marko Rabusin, director of pediatric oncology at Burlo, said during World Child Cancer Day: "Today, children with cancer can be cured."

The world day of children with cancer is celebrated on February 15.The occasion

It is useful for demonstrating advances in research and care for children with oncological pathology.Although relatively rare in industrialized countries, childhood cancer is the leading cause of death from the disease in ages 1–15 years.

First year of life

Progression of acute leukemia and tumors during the first decade of life.

Central nervous system, while lymphomas are more common in adolescents.Deaths are

reduces in relation to the quality of the intervention: in centers where they work like this

Multidisciplinary experts in pediatric oncology, perspective

The cure rate exceeds 80 percent, although there are significant differences between the types of cancer.

In Friuli Venezia Giulia, about 40 new pediatric tumors (age 0-18) are reported every year, and dozens more cases from other regions or abroad should be added.Since its inception in 1984, the IRCCS Burlo Garofolo Children's Oncology Facility has treated more than a thousand children and youth with cancer and performed 480 hematopoietic stem cell transplants.

During the last two decades, more than a hundred young patients have arrived from distant countries: their stay in Trieste, with their families, is almost always made possible thanks to the support, including financial, of associations such as I Bambini del Danubio.

Regional network

Pediatric Oncohematology Network of Friuli Venezia Giulia founded by

District in 2015, organized by Burlo Oncohematología due to the

Having a dedicated medical and nursing team since the 1980s

a system equipped with a hospital with low microbial load rooms for treatment

Immunosuppressed patients and essential services such as surgery and therapy

pediatric intensive care, as well as medical genetics.

Pediatric neoplasms are treated using experimental diagnostic/therapeutic protocols developed by the cooperation of many Italian and European research centers.For this reason, networks have been created in many countries that tend to unite at the transnational level, with the aim of promoting available treatment and their standardization among various participating institutions.

The Italian Association of Pediatric Hemato-Oncology (Aieop) operates in Italy, founded in 1981, whose centers have come together in a national network to improve treatment and assistance for children suffering from cancer, hematological disorders or immunodeficiencies.Aviano/Pordenone.

Because we are seeing improvements

Continuous improvement in healing depends on

Several factors including increasingly effective chemotherapy protocols

contain new drugs (such as monoclonal antibodies and targeted therapies), and i

advances in molecular and genetic analysis.Consequently, significant organizational and technological innovations have taken place in recent years, which are always created with the aim of improving patient care opportunities.

In the organizational area, the establishment of the clinical unit is particularly noteworthy

phase 1 – freezing within Burlo Pediatric Hemato-Oncology – which

It has allowed the initiation of innovative drug trials in pediatrics.

While from a technical point of view this achievement is thanks to the generous donation of AGMEN (Association of Parents of Patients with Neoplastic Haemopathy) of Prodigy equipment dedicated to stem cell transplantation.

Hematopoietic process that allows the manipulation and selection of different populations

Collect cells, that overcome potential immunological and infection barriers

Features of donor transplantation.

Director's words

“Today, it is possible to treat a child suffering from cancer,” explains Doctor Marco Rabusin.

Director of Pediatric Oncology at Burlow, and this is an important finding

The result of significant advances in technology, linked to synergies between operators

health professionals, patient associations and families to create a therapeutic partnership".

It's also available on mobile!Download the app to get updated regularly.